Summary & Overview
CPT 67500: Ocular Injection Into Space Behind Eyeball
CPT code 67500 represents a procedure in which medication is injected into the space behind the eyeball to treat ocular conditions. Nationally, this code captures a specialized ophthalmic injection technique used to deliver drugs directly to the orbit or posterior segment when topical or systemic delivery is inadequate. Accurate coding for 67500 matters for clinical documentation, appropriate site-of-service reporting, and payer adjudication for ophthalmology and hospital outpatient services.
Key payers commonly involved in coverage and reimbursement for this service include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise review of the clinical context for orbital/retrobulbar injections, the typical sites of service where 67500 is reported, and an overview of payer coverage landscape. The publication also outlines benchmarks for utilization and common billing considerations related to procedure reporting and site-of-service designation.
This summary provides a national perspective useful for coding professionals, clinical billing staff, and policy analysts seeking clarity on how 67500 is used clinically and administratively, what payers are typically relevant, and what practical documentation points support accurate submission. Data not available in the input will be noted in the detailed sections.
Billing Code Overview
CPT code 67500 describes an ocular injection procedure in which a provider injects medication into the space behind the eyeball to treat an eye condition. This intraorbital or retrobulbar injection procedure is performed to deliver therapeutic agents directly to structures of the eye and orbit.
Service type: Injection procedure (ocular/intraorbital)
Typical site of service: Ambulatory surgical center, ophthalmology clinic, or hospital outpatient setting, where sterile technique and monitoring are available.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with neovascular (wet) age-related macular degeneration or retinal vein occlusion experiencing sudden central vision decline due to subretinal or intraretinal fluid. The ophthalmologist evaluates the patient in clinic, documents visual acuity, intraocular pressure, anterior segment exam, and dilated fundus exam with optical coherence tomography (OCT) confirming macular edema or choroidal neovascular membrane activity. After informed consent, the patient is prepared in a procedure room or ambulatory surgery center; eyelids and conjunctiva are cleansed with povidone-iodine, a sterile lid speculum is placed, topical anesthetic and optionally subconjunctival anesthetic are given, and a measured dose of intravitreal medication is injected posterior to the limbus into the vitreous cavity to treat the condition. Post‑injection instructions and follow‑up are documented, and the patient is observed briefly for acute complications such as endophthalmitis or elevated intraocular pressure before discharge to home or same‑day clinic follow-up.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when only the physician professional interpretation or service component is billed separate from facility or technical services. |
50 |